These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cognition enhancers between treating and doping the mind. Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672 [TBL] [Abstract][Full Text] [Related]
4. Use of cognitive enhancement medication among northern Italian university students. Castaldi S; Gelatti U; Orizio G; Hartung U; Moreno-Londono AM; Nobile M; Schulz PJ J Addict Med; 2012 Jun; 6(2):112-7. PubMed ID: 22456492 [TBL] [Abstract][Full Text] [Related]
5. Just treat, or enhance? Kennedy D Science; 2004 Apr; 304(5667):17. PubMed ID: 15060288 [No Abstract] [Full Text] [Related]
6. Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions. Tomažič T; Čelofiga AK Philos Ethics Humanit Med; 2019 Apr; 14(1):7. PubMed ID: 31023334 [TBL] [Abstract][Full Text] [Related]
7. American culture and neuro-cognitive enhancing drugs. Flaskerud JH Issues Ment Health Nurs; 2010 Jan; 31(1):62-3. PubMed ID: 19951164 [No Abstract] [Full Text] [Related]
8. Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults. Dubljević V Am J Bioeth; 2013; 13(7):23-33. PubMed ID: 23767434 [TBL] [Abstract][Full Text] [Related]
9. Towards responsible use of cognitive-enhancing drugs by the healthy. Greely H; Sahakian B; Harris J; Kessler RC; Gazzaniga M; Campbell P; Farah MJ Nature; 2008 Dec; 456(7223):702-5. PubMed ID: 19060880 [No Abstract] [Full Text] [Related]
10. [Brain doping: self exploitation by pill]. Klein F MMW Fortschr Med; 2011 Sep; 153(35):21. PubMed ID: 21919245 [No Abstract] [Full Text] [Related]
11. Part II. Cognitive domains for pharmacological intervention: implications for neuropsychiatric and neurological illnesses. Handb Exp Pharmacol; 2015; 228():157-9. PubMed ID: 26317140 [No Abstract] [Full Text] [Related]
12. From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate. Busardò FP; Kyriakou C; Cipolloni L; Zaami S; Frati P Curr Neuropharmacol; 2016; 14(1):17-27. PubMed ID: 26813119 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological cognitive enhancement from a perspective of misuse and addiction]. Franke AG; Soyka M Fortschr Neurol Psychiatr; 2015 Feb; 83(2):83-90. PubMed ID: 25723772 [TBL] [Abstract][Full Text] [Related]